Therapeutic potential of clinically proven natural products in the management of dementia

Farzana Ansari, Md Sohel, Md Mahfujul Haque Haidary, Md Saqline Mostaq, Shamima Akter, Asrafun Nahar, Fatematuz Zohora Labony, Arman Ahmed, Mohammed Shamim Hasan, Mohammad Hasem Babu, Mohammad Nurul Amin. Heliyon. 2024 Feb 27;10(6):e27233.

ReviewHumans

Design

Review

Subjects

Not stated in the abstract

Dose used in the study

Not stated in the abstract

Duration

Not stated in the abstract

What was measured

Which natural products have clinical data supporting use in dementia: a review of PubMed Central, Scopus and Google Scholar literature covering Yokukansan, Souvenaid, BDW, Hupergene, Bacopa monnieri, omega-3, tramiprosate and palmitoylethanolamide.

What the authors reported

Yokukansan, Souvenaid, BDW, Hupergene, Bacopa monnieri, omega-3, tramiprosate and palmitoylethanolamide are named as natural products with reported efficacy against dementia, with proposed mechanisms described. The authors say such products, alone or combined, could treat dementia with fewer side effects, and call for further study.

Limits of this study

A review; the abstract gives no trial numbers, PEA doses or effect sizes. The search and selection method is only briefly described. The authors declare no competing interests.

Source

PubMed 38533051 · doi:10.1016/j.heliyon.2024.e27233

Entry checked against the abstract on PubMed on 2026-09-22. The dose shown is the dose the researchers used. It is not a recommendation. How to read this page.